Agilent Technologies, Inc. $A Shares Acquired by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company increased its position in shares of Agilent Technologies, Inc. (NYSE:A) by 9.7% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 163,805 shares of the medical research company’s stock after buying an additional 14,435 shares during the period. The Manufacturers Life Insurance Company owned about 0.06% of Agilent Technologies worth $21,758,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Greenleaf Trust grew its holdings in Agilent Technologies by 0.8% during the 2nd quarter. Greenleaf Trust now owns 8,117 shares of the medical research company’s stock worth $1,078,000 after acquiring an additional 68 shares in the last quarter. Nilsine Partners LLC raised its holdings in shares of Agilent Technologies by 0.8% in the 2nd quarter. Nilsine Partners LLC now owns 9,650 shares of the medical research company’s stock valued at $1,282,000 after purchasing an additional 72 shares in the last quarter. Fiduciary Trust Co lifted its position in shares of Agilent Technologies by 1.6% during the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock worth $633,000 after purchasing an additional 77 shares during the last quarter. Sapient Capital LLC lifted its position in shares of Agilent Technologies by 4.2% during the 1st quarter. Sapient Capital LLC now owns 2,105 shares of the medical research company’s stock worth $240,000 after purchasing an additional 85 shares during the last quarter. Finally, Integrated Wealth Concepts LLC grew its stake in shares of Agilent Technologies by 0.8% during the second quarter. Integrated Wealth Concepts LLC now owns 11,555 shares of the medical research company’s stock worth $1,535,000 after purchasing an additional 88 shares in the last quarter.

Insider Activity

In other news, Director Mikael Dolsten sold 634 shares of Agilent Technologies stock in a transaction on Friday, September 4th. The shares were sold at an average price of $151.38, for a total value of $95,974.92. Following the transaction, the director directly owned 4,924 shares of the company’s stock, valued at $745,395.12. The trade was a 11.41% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Agilent Technologies Stock Up 2.6%

Shares of NYSE A opened at $146.91 on Friday. The stock has a market cap of $41.42 billion, a PE ratio of 28.92, a price-to-earnings-growth ratio of 2.24 and a beta of 1.24. The company has a quick ratio of 1.56, a current ratio of 2.05 and a debt-to-equity ratio of 0.50. Agilent Technologies, Inc. has a 52-week low of $108.35 and a 52-week high of $163.75. The business has a 50-day moving average price of $143.71 and a 200 day moving average price of $128.62.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, topping the consensus estimate of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.The company had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. During the same quarter in the previous year, the company posted $1.37 earnings per share. The firm’s revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Equities research analysts forecast that Agilent Technologies, Inc. will post 6.2 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A has been the topic of several recent analyst reports. Barclays increased their target price on Agilent Technologies from $150.00 to $175.00 and gave the company an “overweight” rating in a report on Thursday, August 27th. UBS Group initiated coverage on Agilent Technologies in a research report on Wednesday. They set a “neutral” rating and a $165.00 price objective for the company. JPMorgan Chase & Co. upped their price objective on Agilent Technologies from $180.00 to $190.00 and gave the stock an “overweight” rating in a research report on Thursday, August 27th. Weiss Ratings reiterated a “hold (c)” rating on shares of Agilent Technologies in a report on Friday, August 28th. Finally, Jefferies Financial Group initiated coverage on Agilent Technologies in a research report on Thursday, July 9th. They set a “hold” rating and a $135.00 target price on the stock. One analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat, Agilent Technologies has an average rating of “Moderate Buy” and a consensus price target of $170.33.

About Agilent Technologies

Agilent Technologies, Inc is a global provider of analytical instruments, laboratory software, consumables and services used by organizations in the life sciences, diagnostics, pharmaceutical, chemical, environmental and food industries. Its solutions help customers analyze the composition and quality of substances, develop and manufacture products, and conduct research and testing.

The company’s offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic analysis equipment, automated electrophoresis systems, laboratory informatics software, columns and other consumables.